Drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin

The invention discloses a drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, including the following steps: formulating a wild type critical value and a pharmacodynamic critical value of the danofloxacin to the mycoplasma gallisepticum, formulating a dosing sc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FANG SHIWEI, HUANG XIAO, GUO JINLI, CHENG GUYUE, HU SISHUN, PENG DAPENG, WANG SHUGE, GU YUFENG, BI DINGREN, DAI XINYU, CHEN DONGMEI, YUAN ZONGHUI, XIE SHUYU, TAO YANFEI, YU GENGTAO, WANG YULIAN, PAN YUANHU, WANG XU, HUANG LINGLI, QU WEI, HAO HAIHONG, HUANG ANXIONG
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS PHYSICS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention discloses a drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, including the following steps: formulating a wild type critical value and a pharmacodynamic critical value of the danofloxacin to the mycoplasma gallisepticum, formulating a dosing scheme of the danofloxacin to the mycoplasma gallisepticum, formulating a clinical critical value of the danofloxacin to the mycoplasma gallisepticum, and obtaining a drug resistance judgment standard of the danofloxacin to the mycoplasma gallisepticum through a tree diagram which is made through a CLSI susceptibility breakpoint. With the adoption of the drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, the drug resistance judgment standard of the mycoplasma gallisepticum to the danofloxacin can be formulated; stable medication data support can be provided for scientific cultivation; clinical medication can be guided more scientifically; chronic respiratory diseases such as na